Clinical Trials on Myelodysplastic Syndrome in Australia

Total 992 results

University of California, San Francisco
National Institute of Allergy and Infectious Diseases (NIAID); Monash University and other collaborators

Completed

Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study

HIV | Human Immunodeficiency Virus

United States, Australia
Medical University of Graz

Completed

Early Detection of Pulmonary- and Pulmonary Vascular Disease in Sjögren Syndrome

Pulmonary Hypertension | Sjögren Syndrome

Austria
Stanford University

Completed

Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19)

Covid19

Australia
Axsome Therapeutics, Inc.

Unknown

CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1 (CREATE-1)

Reflex Sympathetic Dystrophy | Complex Regional Pain Syndrome

United States, United Kingdom, Australia, Canada
Bayside Health

Completed

Australia and New Zealand Adult Extracorporeal Membrane Oxygenation (ECMO) Audit 2005

Respiratory Insufficiency | Shock, Cardiogenic | Respiratory Distress Syndrome, Adult

Australia
Bayside Health

Terminated

Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection

HIV Infections | Hepatitis C

Australia
Medical University of Vienna

Completed

Biseko Versus Albumin in Systemic Inflammatory Response Syndrome (SIRS) Patients

Systemic Inflammatory Response Syndrome

Austria
Novartis Pharmaceuticals

Completed

A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients

Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients

Austria, Switzerland
The University of Queensland
Metro North Hospital and Health Service; Pathology Queensland

Recruiting

T2 and SeptiCyte RAPID Duration Project

Bacteremia

Australia
Melbourne Health
University of Melbourne; Monash Medical Centre; The Florey Institute of Neuroscience...

Recruiting

High-dose Intravenous Vitamin C in Patients With Septic Shock (HIGH-VIS)

Septic Shock | Sepsis, Severe

Australia
Medical University of Vienna

Unknown

Platelet Function in Patients With an Acute Coronary Syndrome (ATLANTIS-ACS)

Acute Coronary Syndrome (ACS)

Austria
The University of Queensland
Princess Alexandra Hospital, Brisbane, Australia; Macquarie University, Australia

Recruiting

A Practice Change for Patients With Severe Chronic, Clinically Unexplained Gastrointestinal Symptoms

Gastrointestinal Diseases | Irritable Bowel Syndrome

Australia
The Prince Charles Hospital
Sanofi; Merck Sharp & Dohme LLC

Completed

Tirofiban and Enoxaparin in High Risk Coronary Intervention

Acute Coronary Syndrome

Australia
National University Heart Centre, Singapore
AstraZeneca

Recruiting

PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE (PASSIVATE)

Acute Coronary Syndrome

Australia, New Zealand, Singapore
Alexion

Completed

ALXN1210 Versus Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab

Paroxysmal Nocturnal Hemoglobinuria (PNH)

United States, Korea, Republic of, Canada, France, Germany, Spain, United Kingdom, Japan, Australia, Italy, Netherlands
BioCryst Pharmaceuticals

Terminated

A Long Term Safety Study of BCX9930 in Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Paroxysmal Nocturnal Hemoglobinuria | PNH

United Kingdom, Austria, South Africa
Novartis Pharmaceuticals

Terminated

A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome (LOUiSSe)

Sjögren Syndrome

Spain, United States, Belgium, Hungary, Germany, Switzerland, Australia, Denmark, China, Taiwan, United Kingdom, Bulgaria
AstraZeneca

Completed

Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)

Metabolic Syndrome | Dyslipidemia

Australia
Mucpharm Pty Ltd
St George Hospital, Australia; Mobius Medical Pty Ltd.

Completed

Nebulised BromAc in Healthy Volunteers

COVID-19 Pneumonia | COVID-19 Acute Respiratory Distress Syndrome | Bromelains Adverse Reaction | Acetylcysteine Adverse Reaction | Mucus; Plug

Australia
ResMed
The University of Western Australia

Completed

AutoSet for Her Clinical Trial Protocol

Obstructive Sleep Apnea

Australia
Medical University of Vienna

Recruiting

Outcome of Two Surgical Methods for IOLImplantation in Eyes With Pseudoexfoliation Syndrome

Pseudoexfoliation Syndrome | Age Related Cataracts

Austria
Andrew Carr
ViiV Healthcare Australia Pty. Ltd

Completed

The Tolerability of, and Adherence to, Dolutegravir With Co-formulated Tenofovir-emtricitabine for HIV Non-occupational Post-exposure Prophylaxis (dPEP)

Human Immunodeficiency Virus

Australia
Vienna Institute for Research in Ocular Surgery

Unknown

Comparison of the Capsular Stability With Two Different IOL Models in Patients With Pseudoexfoliation Syndrome: an Exploratory Study

Cataract

Austria
Kirby Institute
Merck Sharp & Dohme LLC

Completed

The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection (PINT)

HIV Infection

Australia
The George Institute for Global Health, Australia

Completed

Days Alive and Out of Hospital for Patients With Sepsis

Sepsis | Septic Shock

Australia
Medical University of Vienna
University of Vienna; Griffith University

Recruiting

Brown Adipose Tissue Activity in Gilbert's Syndrome

Gilbert Syndrome

Austria
Glock Health, Science and Research GmbH

Unknown

G-PUR® for Symptomatic Treatment in Irritable Bowel Syndrome With Diarrhea

Irritable Bowel Syndrome With Diarrhea (IBS-D)

Austria
Monash University

Recruiting

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension (RATIONALISE)

Hypogammaglobulinemia | Haematological Malignancy

Australia
Zynerba Pharmaceuticals, Inc.

Completed

Open-Label Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With 22q11.2 Deletion Syndrome (INSPIRE)

22Q Deletion Syndrome

United States, Australia
Flinders University

Completed

Effects of Quetiapine on Sleep and Next Day Alertness in People With Obstructive Sleep Apnea (QOSA)

Sleep Apnea, Obstructive

Australia
Murdoch Childrens Research Institute
Sydney Children's Hospitals Network; Royal Children's Hospital; Monash Health; Royal...

Not yet recruiting

Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2) (VANCAPP)

Infections | Sepsis | Bacteremia

Australia
Flinders University
Bayer

Completed

BAY2586116 Nasal Spray and OSA Severity

Sleep Apnea, Obstructive

Australia
CSL Limited

Completed

Ig NextGen 10% in Patients With Primary Immune Deficiency (PID)

Primary Immune Deficiency (PID)

Australia
University of Aarhus
Odense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaborators

Recruiting

First-line Treatment for Femoroacetabular Impingement Syndrome (BetterHip)

Femoroacetabular Impingement Syndrome

Denmark, Australia
Puzzle Medical Devices Inc.

Not yet recruiting

Feasibility Study to Support Cardiorenal Function in Acute Decompensated Heart Failure With Diuretic Resistance

Heart Failure | Acute Decompensated Heart Failure | Heart Failure With Reduced Ejection Fraction | Heart Failure, Congestive | Heart Failure With Preserved Ejection Fraction | Cardiorenal Syndrome | Diuretic Resistance

Australia
Australian and New Zealand Intensive Care Research...
Monash University

Completed

ICU Recovery in Australian Patients (ICU-RECOVERY)

Intensive Care Unit Syndrome

Australia
Omeros Corporation

Terminated

Intraoperative Floppy Iris Syndrome Undergoing Intraocular Lens Replacement Surgery

Intraocular Lens Replacement | Intraoperative Floppy Iris Syndrome

Austria, Germany
Medical University of Vienna

Recruiting

Infants With Severe Acute Respiratory Distress Syndrome: The Prone Trial

Infant | Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) | Surfactant Dysfunction

Austria
Kirby Institute
National Heart, Lung, and Blood Institute (NHLBI); St Vincent's Hospital, Sydney

Completed

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Cardiovascular Disease | HIV-Associated Lipodystrophy Syndrome

Australia
Bayside Health

Completed

The Use of rTMS to Improve Theory of Mind Among Adults With Autism and Asperger's Disorder

Autistic Disorder | Asperger's Disorder

Australia
Garvan Institute of Medical Research

Completed

Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome

Prader-Willi Syndrome

Australia
Bayer

Completed

Study on the Safety of Drug BAY2586116 and How it Works in Patients With Obstructive Sleep Apnea (a Sleep Disorder Caused by the Narrowing and Collapse of the Airway During Sleep) Including the Blood Level of the Drug and Effect of Its Doses and Routes of Administration (KOALA)

Sleep Apnea, Obstructive

Australia
ImmusanT, Inc.

Completed

Safety and Tolerability of Nexvax2 in Subjects With Celiac Disease

Celiac Disease

New Zealand, Australia
Ludwig Boltzmann Gesellschaft

Unknown

Prophylactic Use of Levosimendan Versus Milrinone in Open Heart Surgery in Infants (Levomil)

Low Cardiac Output Syndrome

Austria
Medical University Innsbruck

Completed

Influence of Cytosorb on Amount of Catecholamine and Mortality in Sepsis

Sepsis | Septic Shock | Cytokine Storm | Cytokine Release Syndrome | Catecholamine

Austria
Olivia Newton-John Cancer Research Institute
Austin Health; La Trobe University

Recruiting

Medical Imaging of Cachexia

Cancer Cachexia

Australia
Novavax

Completed

Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine

Covid19 | SARS-CoV Infection

Australia
Invicta Medical Inc.
Adelaide Institute for Sleep Health, Flinders University

Active, not recruiting

Evaluation of the Effects of Hypoglossal Nerve Stimulation in Humans With Obstructive Sleep Apnea

Sleep Apnea Syndromes | Sleep Apnea, Obstructive | Sleep Disorder | Sleep Apnea

Australia
Ra Pharmaceuticals, Inc.

Terminated

Extension Study of RA101495 for Patients With PNH Who Have Completed a Zilucoplan (RA101495) Clinical Study

Paroxysmal Nocturnal Hemoglobinuria (PNH)

United States, Australia, Canada, Finland, Germany, Hungary, New Zealand, United Kingdom
Medical University of Vienna

Completed

Resilience in Irritable Bowel Syndrome and Gut-focused Hypnotherapy

Irritable Bowel Syndrome

Austria

Clinical Trials on Myelodysplastic Syndrome in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations